Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer
September 18, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology
September 09, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer
September 03, 2024 09:55 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales
August 26, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director
August 20, 2024 17:00 ET
|
Trinity Biotech plc
DUBLIN, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Announces Q2 2024 Financial Results
August 14, 2024 07:30 ET
|
Trinity Biotech plc
-Q2, 2024 total revenues of $15.8 million grew +14% Y/Y and +7.7% Q/Q based on strong demand and output in the TrinScreen HIV business- -Point-of-Care product revenue of $4.6 million grew 119% Y/Y...
Trinity Biotech to Announce Q2 2024 Financial Results
August 13, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics,...
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
August 06, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience
August 02, 2024 09:24 ET
|
Trinity Biotech plc
-Second Quarter 2024 revenues are expected to fall between $15.5-$16.0 million, reflecting double digit percentage year over year growth- -Reiterating financial guidance of approximately $20 million...
Trinity Biotech Announces Appointment of A New CFO
July 09, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, July 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including...